Cost & Affordability
Expert articles and analysis related to cost & affordability.
AI Summary — Last 30 Days
CMS is signaling a more assertive cost-control posture under the Trump administration, with ACO REACH performance showing $706 million in gross spending reductions and particular savings in high-needs, nursing-home-linked populations—evidence that complex-care and post-acute management remain central to Medicare VBC economics (ACO REACH savings). At the same time, CMS finalized a nationwide mandatory joint replacement bundled payment model beginning in 2028 alongside a 2.3% FY2027 inpatient payment update, sharpening
Related Articles
Healthcare affordability, fraud are key issues for voters heading into 2026 midterms
Healthcare affordability, fraud are key issues for voters heading into 2026 midterms Fierce Healthcare
Healthcare Has Confused Disclosure With Understanding
By JOE FEGHALI Healthcare has become very good at producing disclosures. It is much less good at producing understanding. A hospital posts a price file. A health plan publishes negotiated rates. ACont...
New Poll: 94% of Americans Say Congress Must Act on Health Care Costs, as Families USA Convenes Bipartisan Policy Symposium
New Poll: 94% of Americans Say Congress Must Act on Health Care Costs, as Families USA Convenes Bipartisan Policy Symposium Families USA
Delaware passes laws on hospital price caps, PE purchases, financial assistance
Delaware passes laws on hospital price caps, PE purchases, financial assistance Fierce Healthcare
The Drug Changing Medicine
By EMANUEL SARKEES The United States is in the middle of what researchers are calling one of the most significant pharmacological developments in modern medicine. GLP-1 receptor agonists, the drug cla...
Delaware to phase in hospital price caps, expand charity care — 3 things to know
Delaware to phase in hospital price caps, expand charity care — 3 things to know Becker's Hospital Review
Meyer signs trio of healthcare bills: affordability, primary care, hospital oversight
Meyer signs trio of healthcare bills: affordability, primary care, hospital oversight Delaware Business Times
Adding Epcoritamab to R2 in R/R Follicular Lymphoma Meets Cost-Effectiveness Tests
House Committee Advances Bipartisan Bills on Hospital Price Transparency, Medicare Advantage and Drug Pricing Reforms
House Committee Advances Bipartisan Bills on Hospital Price Transparency, Medicare Advantage and Drug Pricing Reforms Families USA
New Bill Seeks to Create Public Option on ACA Marketplaces
New Bill Seeks to Create Public Option on ACA Marketplaces MedCity News